Third Rock Ventures Iii, L.P. Myo Kardia Inc (MYOK) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of MyoKardia Inc. Currently has a direct ownership of 680,272 shares of MYOK, which is worth approximately $153 Million. The most recent transaction as insider was on Jan 03, 2018, when has been sold 816,326 shares (Common Stock) at a price of $42.0 per share, resulting in proceeds of $34,285,692. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 680K

0% 3M change

0% 12M change

Total Value Held $153 Million

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 03 2018	SELL Open market or private sale	$34,285,692 $42.0 p/Share	816,326 Reduced 54.55%	680,272 Common Stock

Also insider at

RLAY

Relay Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

NRIX

Nurix Therapeutics, Inc. Healthcare

> 10% Shareholder

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

> 10% Shareholder

VYGR

Voyager Therapeutics, Inc. Healthcare

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

TRV